Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Zeldox 40mg capsules
0402010AGBBAAAA
|
Zeldox | Ziprasidone hydrochloride | Central Nervous System | 1 |
|
Ziprasidone 40mg capsules
0402010AGAAAAAA
|
Ziprasidone hydrochloride | Ziprasidone hydrochloride | Central Nervous System | 1 |
|
Zeldox 60mg capsules
0402010AGBBACAC
|
Zeldox | Ziprasidone hydrochloride | Central Nervous System | No data available |
|
Zeldox 80mg capsules
0402010AGBBABAB
|
Zeldox | Ziprasidone hydrochloride | Central Nervous System | No data available |
|
Ziprasidone 20mg capsules
0402010AGAAADAD
|
Ziprasidone hydrochloride | Ziprasidone hydrochloride | Central Nervous System | No data available |
|
Ziprasidone 60mg capsules
0402010AGAAACAC
|
Ziprasidone hydrochloride | Ziprasidone hydrochloride | Central Nervous System | No data available |
|
Ziprasidone 80mg capsules
0402010AGAAABAB
|
Ziprasidone hydrochloride | Ziprasidone hydrochloride | Central Nervous System | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.